Treatment of Gaucher's disease with OGT 918
- PMID: 10968454
- DOI: 10.1016/s0140-6736(00)02618-0
Treatment of Gaucher's disease with OGT 918
Comment on
-
Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.Lancet. 2000 Apr 29;355(9214):1481-5. doi: 10.1016/S0140-6736(00)02161-9. Lancet. 2000. PMID: 10801168 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
